scholarly journals Sulfatase-cleavable linkers for antibody-drug conjugates

2020 ◽  
Vol 11 (9) ◽  
pp. 2375-2380 ◽  
Author(s):  
Jonathan D. Bargh ◽  
Stephen J. Walsh ◽  
Albert Isidro-Llobet ◽  
Soleilmane Omarjee ◽  
Jason S. Carroll ◽  
...  

Arylsulfate-containing linkers are cleaved by lysosomal sulfatases to release payloads from ADCs at targeted cancer cells.

2016 ◽  
Vol 15 (6) ◽  
pp. 1311-1320 ◽  
Author(s):  
Rajeeva Singh ◽  
Yulius Y. Setiady ◽  
Jose Ponte ◽  
Yelena V. Kovtun ◽  
Katharine C. Lai ◽  
...  

2014 ◽  
Vol 13 ◽  
pp. CIN.S19222 ◽  
Author(s):  
Arianna Filntisi ◽  
Dimitrios Vlachakis ◽  
George K. Matsopoulos ◽  
Sophia Kossida

Antibody-drug conjugates (ADCs) constitute a category of anticancer targeted therapy that has gathered great interest during the last few years because of their potential to kill cancer cells while causing significantly fewer side effects than traditional chemotherapy. In this paper, a process of computational construction of ADCs is described, using the surface lysines of an antibody and a non-covalent linker molecule, as well as a cytotoxic substance, as files in Protein Data Bank format. Also, aspects related to the function, properties, and development of ADCs are discussed.


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Yamato Kikkawa ◽  
Yurie Enomoto-Okawa ◽  
Aiko Fujiyama ◽  
Takeshi Fukuhara ◽  
Nozomi Harashima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document